Immunotherapy and Oncogenic Pathways: The PTEN Connection

Tekijä Rizvi, Naiyer, Chan, Timothy A.
Julkaisussa Cancer Discov (2016)

PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?

Tekijä Grigg, Claud, Rizvi, Naiyer A.
Julkaisussa J Immunother Cancer (2016)

Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion

Tekijä Reed, Vanessa A., Rizvi, Naiyer
Julkaisussa Oncologist (2019)

Into the Clinic With Nivolumab and Pembrolizumab

Tekijä Shu, Catherine A., Rizvi, Naiyer A.
Julkaisussa Oncologist (2016)

Genomic profile, smoking, and response to anti-PD-1 therapy in non-small cell lung carcinoma

Tekijä Hellmann, Matthew, Rizvi, Naiyer, Wolchok, Jedd D., Chan, Timothy A.
Julkaisussa Mol Cell Oncol (2015)

Genetics and immunology: reinvigorated

Tekijä Snyder, Alexandra, Makarov, Vladimir, Hellmann, Matthew, Rizvi, Naiyer, Merghoub, Taha, Wolchok, Jedd D, Chan, Timothy A
Julkaisussa Oncoimmunology (2015)

Quantitative method for the determination of Iso-fludelone (KOS-1803) in human plasma by LC-MS/MS

Tekijä Christner, Susan M., Parise, Robert A., Levine, Erica D., Rizvi, Naiyer A., Gounder, Mrinal M., Beumer, Jan H.
Julkaistu 2014

IMCT-18 PD-1 INHIBITORS FOR RECURENT HIGH GRADE GLIOMA (HGG)

Tekijä Schaff, Lauren, Donovan, Laura, Lassman, Andrew B., Wang, Tony, Carvajal, Richard, Rizvi, Naiyer, Fox, Alyson, Iwamoto, Fabio M.
Julkaisussa Neuro Oncol (2015)

Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced non-squamous non-small cell lung cancers

Tekijä Hellmann, Matthew D, Sturm, Isrid, Trnkova, Zuzana Jirakova, Lettieri, John, Diefenbach, Konstanze, Rizvi, Naiyer A., Gettinger, Scott N.
Julkaisussa Clin Lung Cancer (2015)

Clinical and in vivo Evidence that EGFR S768I Mutant Lung Adenocarcinomas Are Sensitive to Erlotinib

Tekijä Hellmann, Matthew D., Reva, Boris, Yu, Helena, Rusch, Valerie W, Rizvi, Naiyer A, Kris, Mark G, Arcila, Maria E
Julkaisussa J Thorac Oncol (2014)

Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC

Tekijä Aerts, Hugo J. W. L., Grossmann, Patrick, Tan, Yongqiang, Oxnard, Geoffrey G., Rizvi, Naiyer, Schwartz, Lawrence H., Zhao, Binsheng
Julkaisussa Sci Rep (2016)

Corrigendum: Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC

Tekijä Aerts, Hugo J. W. L., Grossmann, Patrick, Tan, Yongqiang, Oxnard, Geoffrey R., Rizvi, Naiyer, Schwartz, Lawrence H., Zhao, Binsheng
Julkaisussa Sci Rep (2017)

Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung canc...

Tekijä Brahmer, Julie, Balmanoukian, Ani, Goldberg, Sarah, Ou, Sai-Hong, Blake-Haskins, Andrew, Karakunnel, Joyson, Stockman, Paul, Rizvi, Naiyer, Antonia, Scott
Julkaisussa J Immunother Cancer (2014)

A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-s...

Tekijä Urba, Walter, Chmielowski, Bartosz, Loo, Deryk, Baughman, Jan, Chen, Francine, Moore, Paul, Bonvini, Ezio, Vasselli, James, Wigginton, Jon, Rizvi, Naiyer
Julkaisussa J Immunother Cancer (2015)

Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients

Tekijä Cassileth, Barrie R., Rizvi, Naiyer, Deng, Gary, Yeung, K. Simon, Vickers, Andrew, Guillen, Stacey, Woo, Derek, Coleton, Marci, Kris, Mark G.
Julkaistu 2009

Pack Years of Cigarette Smoking as a Prognostic Factor in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

Tekijä Janjigian, Yelena Y., McDonnell, Kevin, Kris, Mark G., Shen, Ronglai, Sima, Camelia S., Bach, Peter B., Rizvi, Naiyer A., Riely, Gregory J.
Julkaistu 2010

Core Needle Lung Biopsy Specimens: Adequacy for EGFR and KRAS Mutational Analysis

Tekijä Solomon, Stephen B., Zakowski, Maureen F., Pao, William, Thornton, Raymond H., Ladanyi, Marc, Kris, Mark G., Rusch, Valerie W., Rizvi, Naiyer A.
Julkaistu 2010

Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas

Tekijä Lampen-Sachar, Katharine, Zhao, Binsheng, Zheng, Junting, Moskowitz, Chaya S, Schwartz, Lawrence H, Zakowski, Maureen F, Rizvi, Naiyer A, Kris, Mark G, Ginsberg, Michelle S
Julkaisussa Lung Cancer (2011)

Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib

Tekijä Johnson, Melissa L., Riely, Greg J., Rizvi, Naiyer A., Azzoli, Christopher G., Kris, Mark G., Sima, Camelia S., Ginsberg, Michelle S., Pao, William, Miller, Vincent A.
Julkaistu 2011

Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

Tekijä Chowell, Diego, Krishna, Chirag, Pierini, Federica, Makarov, Vladimir, Rizvi, Naiyer A., Kuo, Fengshen, Morris, Luc G. T., Riaz, Nadeem, Lenz, Tobias L., Chan, Timothy A.
Julkaisussa Nat Med (2019)